An In vitro rapid qualitative test that detects influenza type A & type B antigens directly from nasal swab, nasopharyngeal swab, and nasal aspirate/wash specimens.

• Defferenciates between Inlfuenza Type A & B, on a sigle test device
• Get results in 10–15 minutes
• Each test device has built in controls
• Each kit comes with external controls
• Meets FDA preformance criteria for Influenza tests stated in code 21 CFR 866.3328

CLIA Complexity: Moderate complexity when used with Nasal Wash/Aspirate samples. CLIA Waived when used with nasal and nasopharyngeal swabs.

It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections, from the same specimen.